IVIRMA, backed by KKR, acquires Eugin's activities in North America and Canada

ARCANO has acted as exclusive financial advisor to IVIRMA, backed by world-leading financial sponsor KKR, on the acquisition of Eugin, one of the global references in assisted reproduction, from the German private healthcare group Fresenius. IVIRMA has acquired Eugin's activities in North America (U.S. and Canada) while GED Capital has acquired Eugin's businesses in Europe and LatAm across 9 countries. Thus, IVIRMA consolidates itself as the undisputable leader in the market worldwide.

Fertility treatments

IVIRMA is the world’s leading reproductive medicine group present across 14 countries, with leading industry results and the most innovative R&D platform. Their goal is to continue to cement their global leadership position in providing the best outcomes for patients.

Founded in 1976, KKR sponsors investment funds globally that invest in private equity, credit, and real assets. The firm aims to generate attractive investment returns by following a patient and disciplined approach, employing high-quality people, and pursuing the highest standards of excellence.

Eugin is an assisted reproduction company founded in Barcelona over 25 years ago, operating in 11 countries through more than 69 clinics. The company performs over 45,000 treatments a year, with the help of its more than 1,700 specialists in human reproduction.

GED is a Spanish, independent asset manager founded in 1996 that operates in the middle-market segment. It currently manages more than €1 billion through various private equity, infrastructure and venture capital vehicles.